Skip Nav Destination
LETTER|
July 15, 1996
A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia [letter]
Blood (1996) 88 (2): 756.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal